Buy
Average AnalystUnder-perform
Top AnalystNeutral
Stock Target AdvisorN/A
Average UserUSD 38.94
-0.26 (-0.66)%
USD 2.79B
0.63M
USD 37.56(-3.56%)
Symbol | Name | Exchange | VCYT's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
Global X Genomics & Biote.. | LSE | 4.99 % | 0.50 % | +0.05 (+0.99%) | USD8.22M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.